Georgia's Online Cancer Information Center

Doug Russell: “I was not going to let the cancer beat me.”


Doug Russell

“I was not going to let the cancer beat me.”

The first piece of news was ominous: Doug Russell had stage 4 melanoma.

The second was worse: The cancer had spread to his lungs.

“Like everyone who is first diagnosed, I was devastated,” says the building supply company executive from Duluth, Ga. “But I quickly learned that you’ve got to move past the negative feelings and get into the ready-to-fight stage.”

At first, the fight didn’t go so well; standard treatments yielded poor results.

So Doug’s physician, Dr. David Lawson at Emory’s Winship Cancer Institute in Atlanta, recommended an aggressive series of Interleukin-2 treatments – a therapy that was only available through a clinical trial.

“I wasn’t very familiar with clinical trials,” Doug said, “but I wanted to do anything I could to get better. Plus, having the opportunity to help other people was a strong incentive. I knew that my participation meant I might help save other lives.”

Five years after his first diagnosis, Doug was cancer free. He credits the IL-2 treatments from the clinical trial for his recovery as well as his keeping a positive outlook throughout therapy.

“I didn’t want to know what the side effects might be because I didn’t want to focus on them,” he says. “I went into every protocol just knowing that it would work.”

Back to Survivors' Voices

Survivorship

Lawmakers conclude listening tour on access to cancer care

Rep. Lee Hawkins, R-Gainesville, the committee’s chairman, said he and other lawmakers are working on drug pricing and other issues. He wrapped up the committee’s listening tour by saying the General Assembly will continue to study cancer care access.

7/14/2025

PCOM S. Georgia student receives third cancer research award

Med student from south Georgia wins awards to advance cancer research.

5/08/2025

GCRCCP honored by ACS National Colorectal Cancer Roundtable

The Georgia Colorectal Cancer Control Program won the 2025 American Cancer Society's NCCRT National Achievement Award.

3/04/2025